Trial Details

COMPLETED
Basic Information
Clinical ID c3674
Identifier NCT01696396
Trial Title Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn's Disease
Interventions DRUG: Abrilumab|DRUG: Placebo
Participant Information
Sponsor Amgen
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2012-12-04
Primary Completion Date 2014-12-26
Completion Date 2018-04-10